Skip to main content

Table 4 Time from appearance of first PAH symptoms and diagnosis

From: Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry

PAH subtype

Time between first symptoms and diagnosis (months)

 

Total (n = 156)

Prevalent cases (n = 79)

Incident cases (n = 77)

p*

Idiopathic

    

Mean (SD)

36 (42)

36 (42)

37 (44)

0.742

Median (25th-75th; 5th-95th)

23 (10–49/2–120)

22 (7–48/1–120)

24 (10–60/2–96)

 

APAH-CHD

    

Mean (SD)

52 (63)

31 (45)

62 (69)

0.244

Median (25th-75th; 5th-95th)

24 (8–96/0–251)

21 (2–24/0–120)

36 (24–96/1–251)

 

APAH-CTD

    

Mean (SD)

31 (46)

47 (59)

13 (8)

0.139

Median (25th-75th; 5th-95th)

12 (8–24/2–192)

24 (12–60/6–192)

12 (6–15/2–24)

 

Heritable

    

Mean (SD)

51 (93)

15 (13)

69 (114)

0.605

Median (25th-75th; 5th-95th)

13 (10–24/5–240)

15 (5–24/5–24)

13 (10–14/10–240)

 

Total

    

Mean (SD)

39 (48)

36 (43)

42 (52)

0.523

Median (25th-75th; 5th-95th)

24 (10–49/1–120)

22 (8–48/1–120)

24 (10–60/2–120)

 
  1. APAH-CHD, pulmonary arterial hypertension associated with congenital heart disease; APAH-CTD, pulmonary arterial hypertension associated with connective tissue disease.
  2. *Difference between prevalent and incident cases Mann–Whitney U test.